Bio Special
Teijin and Cell Therapies Forge a Cross-Border Alliance to Accelerate Cell and Gene Therapy Access Between Japan and Australia
As the cell and gene therapy (CGT) sector moves from scientific promise to large-scale reality, collaboration between nations with strong translational and...
October 06, 2025 | News | By arcilla.fran@biopharmaapac.com
Takeda Steps Back from Cell & Gene Therapy to Refocus on Predictable Growth
Takeda Pharmaceutical, one of the world’s most globalised pharma companies, has confirmed it will step away from in-house development of its cell and...
October 05, 2025 | News
Redefining Cancer Care in Southeast Asia: Siemens Healthineers’ Fabrice Leguet on Turning Awareness into Action
Cancer care in Southeast Asia stands at a critical crossroads. While awareness of early detection is high, the translation into meaningful action remains p...
October 01, 2025 | Interaction | By arcilla.fran@biopharmaapac.com
South Korea’s Celltrion Buys Eli Lilly’s Branchburg Plant in $330M Deal
Celltrion Group announced that its US subsidiary, Celltrion USA, has entered into a definitive agreement to acquire Eli Lilly’s biologics manufacturi...
September 25, 2025 | News
Single-Use Systems Are Rewiring Biopharma Manufacturing
Bioprocess, Unbottled Single-use systems (SUS) have become a transformative force in biopharmaceutical processing, offering an alternative to trad...
September 16, 2025 | Report
The State of Biotech and Life Science Jobs in Asia Pacific – 2025
In 2025, Asia-Pacific has emerged as the fastest-growing hub for biotech and life sciences employment, fuelled by a powerful combination of government supp...
September 09, 2025 | Report
Epigenic Therapeutics Raises $60 Million in Series B Financing to Advance Epigenetic Medicine Pipeline
Epigenic Therapeutics ("Epigenic"), a clinical-stage innovative drug development company, today announced the completion of a $60 million Series ...
September 09, 2025 | News
Thermo Fisher Expands Strategic Partnership with Sanofi through Acquisition of Ridgefield Sterile Manufacturing Site
Expanded Strategic Partnership Enables Additional U.S. Manufacturing Capacity to Serve Increased Demand for Pharma/Biotech Customers Thermo Fisher Scienti...
September 03, 2025 | News
Transforming Cancer Care in Japan and Asia-Pacific: Thermo Fisher’s Jane Li on Accelerating Precision Oncology with Next-Gen Diagnostics
BioPharma APAC spoke with Jane Li, Senior Director, Pharma CDx and CRO Partnership at Thermo Fisher Scientific, about the development of the Oncomine&trade...
August 25, 2025 | Expert Insight
Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Invisible chemical impurities in medicines can pose very visible risks to patient safety and pharmaceutical reputations. In recent years, a quiet c...
August 19, 2025 | Analysis
“Spatial Biology at Scale: 10x Genomics CEO Serge Saxonov on Redefining Precision Medicine with TISHUMAP”
The future of medicine is being shaped at the intersection of spatial biology and artificial intelligence—and 10x Genomics is l...
August 07, 2025 | Interaction
Bridging Real-World Evidence and AI: Unlocking Smarter, Faster Clinical Research in Asia
Having worked with pharma clients, healthcare providers, and digital platforms across the Asia-Pacific region, I’ve seen the challenges first-hand&md...
August 04, 2025 | Opinion
Precision Therapies Set to Unlock USD 1.6 Trillion in Economic Impact Across Asia-Pacific
As Asia-Pacific bears nearly half of the global cancer burden, precision medicine is emerging not only as a clinical breakthrough but also as a powerful ec...
August 04, 2025 | Interview
Fighting Dengue in a Changing Climate: Takeda’s Vision for Resilient Health Systems in Emerging Markets
Dengue is no longer a seasonal threat. It is a growing climate-driven crisis. With rising global temperatures, shifting rainfall patterns and rapid urbanis...
August 04, 2025 | Expert Insight
Most Read
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
